medigraphic.com
ISSN 2520-9078 (Electronic)

2021, Number 4

<< Back Next >>

Revista de Ciencias Médicas de la Habana 2021; 28 (4)

Genetics, Genomic and COVID-19: ethical implications

Quintana HD, Rojas BIA, Quintana MD, Fajardo PY, Oviedo CL

Language: Spanish
References: 30
Page: 588-601
PDF size: 1063.54 Kb.


ABSTRACT

Introduction: Genetics and Genomic contribute to the development of personalized approaches and more effective for prevention and treatment of infectious diseases. During the current pandemics, genomic studies have been performed to patients with COVID-19 or expossed, non affected, to trace the factors of the associated host with the variability in the susceptibility, the infectivity and critical condition of the disease.
Objective: To describe the ethical implications genetics and genomic in the clinical practice and public health during COVID-19 pandemic.
Methods: Bibliographic bases such as PubMed/Medline and Google Scholar were consulted. The ethical implications, benefits and damages related to the genetics and genomic studies are described, in the clinical practice and public health in COVID-19.
Conclusions: The genetics and genomic studies developed during COVID-19 pandemic represent an achievement of the global coordination and cooperation.


REFERENCES

  1. Organización Mundial de la Salud. Coronavirus Disease (COVID-19) Dashboard. Data last updated: 2020/11/27 [Internet]. Ginebra: OMS; 2020 [citado 27 nov 2020]. Disponible en: https://covid19. who. int/

  2. Ministerio de Salud Pública de Cuba. Informe epidemiológico COVID-19, 27/11/2020. [citado 27 nov 2020]. Disponible en: https://salud. msp. gob. cu/

  3. Liu Y, Häussinger L, Steinacker JM, Dinse-Lambracht A. Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution. Epidemiol Infect[Internet]. 2021 Jan 7[citado 13 Dic 2021];149:e19. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7844181/

  4. American Association for the Advancement of Science[Internet]. Washington, DC: American Association for the Advancement of Science; © 2021. How sick will the coronavirus make you? The answer may be in your genes. [citado 13 Dic 2021]. Disponible en: https://www. science. org/content/article/how-sick-will-coronavirus-make-you-answer-may-be-your-genes

  5. Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Hum Genet[Internet]. 2020[citado 13 Dic 2021];28(6):715–8. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7220587/

  6. Solomon I, Harrington E, Hooker G, Erby L, Axilbund J, Hampel H, et al. Lynch syndrome limbo: patient understanding of variants of uncertain significance. J Genet Couns[Internet]. 2017[citado 13 Dic 2021];26(4):866–77. Disponible en: https://onlinelibrary. wiley. com/doi/full/10. 1007/s10897-017-0066-y

  7. Brabbing Goldstein D, Reches A, Svirsky R, Bar Shira A, Yaron Y. Dilemmas in genetic counseling for low-penetrance neuro-susceptibility loci detected on prenatal chromosomal microarray analysis. Am J Obstet Gynecol[Internet]. 2018[citado 13 Dic 2021];218(2): 247. e1-247. e12. Disponible en: https://www. sciencedirect. com/science/article/abs/pii/S0002937817323244?via%3Dihub

  8. Brothers KB, Rothstein MA. Ethical, legal and social implications of incorporating personalized medicine into healthcare. Per Med[Internet]. 2015[citado 13 Dic 2021];12(1):43-51. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC4296905/

  9. Boyce AM, Garibaldi BT. Genomics and high-consequence infectious diseases: a scoping review of emerging science and potential ethical issues. Health Secur[Internet]. 2019 Jan/Feb[citado 13 Dic 2021];17(1):62-8. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC6424158/

  10. Walker A, Boyce A, Duggal P, Thio CL, Geller G. Genomics and infectious diseases: expert perspectives on public health considerations regarding actionability and privacy. Ethics Hum Res[Internet]. 2020 May[citado 13 Dic 2021];42(3):30-40. Disponible en: https://onlinelibrary. wiley. com/doi/epdf/10. 1002/eahr. 500051

  11. Kuo C-L, Pilling LC, Atkins JL, Masoli J, Delgado J, Kuchel GA, et al. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci[Internet]. 2020[citado 13 Dic 2021];75(11):2231–2. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7314139/pdf/glaa131. pdf

  12. Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell[Internet]. 2019[citado 13 Dic 2021];177(1):26–31. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7380073/

  13. Mills MC, Rahal C. The GWAS Diversity Monitor tracks diversity by disease in real time. Nat Genet[Internet]. 2020[citado 13 Dic 2021];52(3):242–3. Disponible en: https://www. ncbi. nlm. nih. gov/pubmed/32139905

  14. Milne R. Societal considerations in host genome testing for COVID-19. Genet Med[Internet]. 2020[citado 13 Dic 2021]; 22:1464–6. Disponible en: https://www. nature. com/articles/s41436-020-0861-y. pdf

  15. Greninger AL. Societal implications of the internet of pathogens. J Clin Microbiol[Internet]. 2019[citado 13 Dic 2021];57(6):e01914–e18. Disponible en: https://journals. asm. org/doi/epub/10. 1128/JCM. 01914-18

  16. Walker A, Boyce A, Geller G, Thio CL, Kahn JP. Direct-acting antivirals and hepatitis C: the ethics of price and rationing by genotype. Clin Infect Dis[Internet]. 2018[citado 13 Dic 2021];67(6):983–4. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7190899/

  17. US Equal Employment Opportunity Commission[Internet]. Washington, DC: US Equal Employment Opportunity Commission; c2020. What you should know about COVID-19 and the ADA, the Rehabilitation Act, and other EEO laws. [citado 13 Dic 2021]. Disponible en: https://www. eeoc. gov/wysk/what-you-should-know-about-covid-19-and-ada-rehabilitation-act-and-other-eeo-laws

  18. Bentley AR, Callier SL, Rotimi CN. Evaluating the promise of inclusion of African ancestry populations in genomics. npj Genom Med[Internet]. 2020[citado 13 Dic 2021];5(5):1–9. Disponible en: https://www. nature. com/articles/s41525-019-0111-x. pdf

  19. Valdés Fernández BN, Duconge J, Espino AM, Ruaño G. Personalized health and the coronavirus vaccines-Do individual genetics matter? Bioessays[Internet]. 2021 Sep[citado 13 Dic 2021];43(9):e2100087. Disponible en: https://onlinelibrary. wiley. com/doi/epdf/10. 1002/bies. 202100087

  20. Molster CM, Bowman FL, Bilkey GA, Cho AS, Burns BL, Nowak KJ, Dawkins HJS. The Evolution of Public Health Genomics: Exploring Its Past, Present, and Future. Front Public Health[Internet]. 2018 Sep 4[citado 13 Dic 2021];6:247. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC6131666/

  21. Lantos JD. Ethical and Psychosocial Issues in Whole Genome Sequencing (WGS) for Newborns. Pediatrics[Internet]. 2019 Jan[citado 13 Dic 2021];143(Suppl 1):S1-S5. Disponible en: https://publications. aap. org/pediatrics/article/143/Supplement_1/S1/34201/Ethical-and-Psychosocial-Issues-in-Whole-Genome

  22. Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med[Internet]. 2017 Mar[citado 13 Dic 2021];19(3):283-93. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC5447864/pdf/gim2016109a. pdf

  23. Martinez-Martin N, Magnus D. Privacy and ethical challenges in next-generation sequencing. Expert Rev Precis Med Drug Dev[Internet]. 2019[citado 13 Dic 2021];4(2):95-104. https://www. ncbi. nlm. nih. gov/pmc/articles/PMC7413244/

  24. Kost RG, Poppel SM, Coller BS. Informed consent for next-generation nucleotide sequencing studies: Aiding communication between participants and investigators. J Clin Transl Sci[Internet]. 2017 Apr[citado 13 Dic 2021];1(2):115-120. Disponible en: https://www. cambridge. org/core/journals/journal-of-clinical-and-translational-science/article/informed-consent-for-nextgeneration-nucleotide-sequencing-studies-aiding-communication-between-participants-and-investigators/2B0293050882D3F0A240726367293B13

  25. Marchant G, Barnes M, Evans JP, LeRoy B, Wolf SM, Law Seq Liability Task Force. From genetics to genomics: facing the liability implications in clinical care. J Law Med Ethics[Internet]. 2020 Mar;48(1):11-43. Disponible en: https://journals. sagepub. com/doi/full/10. 1177/1073110520916994

  26. Coller BS. Ethics of human genome editing. Annu Rev Med[Internet]. 2019 Jan [citado 25 Abr 2021];70:289-305. Disponible en: https://doi:10. 1146/annurev-med-112717-094629

  27. Geller G, Duggal P, Thio CL, Mathews D, Kahn JP, Maragakis LL, et al. Genomics in the era of COVID-19: ethical implications for clinical practice and public health. Genome Med[Internet]. 2020 Nov[citado 25 Abr 2021];12(1):95. Disponible en: https://genomemedicine. biomedcentral. com/articles/10. 1186/s13073-020-00792-9

  28. Kumar S, Jha S, Rai SK. Significance of super spreader events in COVID-19. Indian J Public Health[Internet]. 2020 Jun[citado 25 Abr 2021]; 64(Suppl 2):S139-S141. Disponible en: https://www. ijph. in/temp/IndianJPublicHealth646139-6531668_180836. pdf

  29. Rotimi CN, Marshall PA. Tailoring the process of informed consent in genetic and genomic research. Genome Med[Internet]. 2010 [citado 25 Abr 2021];2:20. Disponible en: https://www. ncbi. nlm. nih. gov/pmc/articles/PMC2873798/

  30. Fariñas Acosta L. Cuba en busca del riesgo genético ante la COVID-19 [Internet]. Cubadebate. La Habana: UCI; © 2014 [actualizado 3 Nov 2020; citado 25 Abr 2021]. Disponible en: http://www. cubadebate. cu/especiales/2020/11/03/cuba-en-busca-del-riesgo-genetico-ante-la-covid-19/




2020     |     www.medigraphic.com